Table 6. Major adverse cardiovascular events of the patients followed-up.

MACE	CAD Patients(n = 408)			Non CAD Patients(n = 367)
	CT group(n = 137)	NCT group(n = 271)	p value	CT group(n = 165)	NCT group(n = 202)	p value
the primary end point
cardiac death	2(1.5)	6(2.2)	0.604	1(0.6 )	1(0.5 )	0.886
cardiac death due to CAD	1(0.7)	6(2.2)	0.276	0(0)	1(0.5)	0.365
acute myocardial infarction	5(3.6)	13(4.8)	0.594	0(0 )	2(1.0)	0.200
the secondary end point
all cause mortality	4(2.9)	10(3.7)	0.686	2(1.2)	3(1.5)	0.822
coronary revascularization	13(9.5)	39(14.4)	0.161	1(0.6 )	1(0.5)	0.886
non-fatal angina needing hospital admission	50(36.5)	103(38.0)	0.766	1(0.6 )	1(0.5)	0.886
stroke	12(8.8)	33(12.7)	0.298	7(4.2)	9(4. 5)	0.921
composite end point	55(40.1)	130(48.0)	0.134	11(6.7)	13(6.4)	0.929